390 results on '"Gheorghe, Liana"'
Search Results
102. Tu1053 The Value of Contrast Enhanced Ultrasound (CEUS) for Focal Liver Lesions Characterization - A Multicenter Romanian Study
103. Su1294 Epidemiological Characteristics of Chronic Hepatitis DELTA Virus Infection (CHD) in Romania
104. The prevalence and risk factors of hepatitis B virus infection in an adult population in Romania
105. Adalimumab and Infliximab in Crohn's disease - real life data from a national retrospective cohort study.
106. Su2040 Liver Stiffness Value Assessed by Transient Elastography Correlates With Nodule Size in Patients With Hepatocellular Carcinoma
107. Sa1604 Mucosal Healing in Patients With Ulcerative Colitis Assessed by Confocal Laser Endomicroscopy
108. Pegylated Interferon Alpha-2B for the Management of Patients With Chronic Hepatitis Delta
109. S1737 Model to Predict Crohn's Disease Behaviour Using Mucosal Inflammatory Genes Expression Profile and ASCA Titers
110. Prevalence of hepatitis C in Romania: Different from European rates?
111. T1947 Real-Time Elastography - a Pilot Study for Non-Invasive Detection of Small Hepatocellular Carcinoma in Cirrhotic Patients
112. Predictors of Graft and Patient Survival in Hepatitis C Virus (HCV) Recipients: Model to Predict HCV Cirrhosis After Liver Transplantation
113. Epidemiology of inflammatory bowel disease in adults who refer to gastroenterology care in Romania
114. Frequency and predictive factors for overlap syndrome between autoimmune hepatitis and primary cholestatic liver disease
115. Homozygous familial hypercholesterolemia: specific indication for domino liver transplantation
116. Effect of high-calorie, high-protein diet in cirrhotic patients with hepatic encephalopathy
117. Prophylactic banding ligation of high risk esophageal varices inpatients on the waiting list for liver transplantation: an interim report
118. Liver steatosis in chronic hepatitis C: a factor of severity?
119. Compliance of cirrhotic patients with spontaneous bacterial peritonitis to prophylacyic antibiotic therapy: influence on recurrence
120. Do the needle type and the operator experience influence liver biopsy specimen quality?
121. Dynamics of the Romanian Waiting List for Liver Transplantation after Changing Organ Allocation Policy.
122. Primary Focal T-cell Lymphoma of the Liver: a Case Report and Review of the Literature.
123. Weight-Based Dosing Regimen of Peg-Interferon α-2b for Chronic Hepatitis Delta: a Multicenter Romanian Trial.
124. How Severe Is Chronic Hepatitis with HCV Genotype 1b? A Study of 1,220 Cases on the Waiting List for Antiviral Therapy in Romania.
125. The Prevalence and Risk Factors of Hepatitis C Virus Infection in Adult Population in Romania: a Nationwide Survey 2006 - 2008.
126. Access to Peginterferon plus Ribavirin Therapy for Hepatitis C in Romania between 2002-2009.
127. Real Time Elastography -- a Non-invasive Diagnostic Method of Small Hepatocellular Carcinoma in Cirrhosis.
128. Experimental determination of blood permittivity and conductivity in simple shear flow.
129. THU398 - A real-world study of treating advanced liver cirrhosis due to chronic HCV infection genotype 1b with sofosbuvir+ ledipasvir with or without ribavirin: results from a cohort of 349 patients.
130. The experience of a Romanian oncology department with bevacizumab (Bev) in the treatment of metastatic colorectal cancer.
131. The Staging of Newly Diagnosed Hepatocellular Carcinoma in Romania. A National Multicentric Study.
132. How severe is chronic hepatitis with HCV genotype 1b? a study of 1,220 cases on the waiting list for antiviral therapy in Romania
133. The Value of Contrast Enhanced Ultrasound (CEUS) for Focal Liver Lesions Characterization - A Multicenter Romanian Study
134. The influence of clinical significant portal hypertension (stage Baveno 2) on safety, tolerability and efficacy of paritaprevir, ritonavir, ombitasvir, dasabuvir and ribavirin (PrOD plus R) in a real-world large cohort of genotype 1b HCV liver cirrhosis patients
135. Clostridium difficile infection in gastroenterology settings: more frequent or better diagnosed?
136. Budd Chiari syndrome and V617F/JAK 2 mutation linked with the myeloproliferative disorders.
137. Low prevalence and mild course of inflammatory bowel diseases in South Eastern Europe.
138. Reply: To the Editor.
139. Influența virusului hepatitic delta asupra istoriei naturale a cirozei hepatice compensate cu virus hepatitic B.
140. Intravenous versus subcutaneous delivery of biotherapeutics in IBD: an expert's and patient's perspective.
141. Risk Factors for Extraintestinal Manifestations in Inflammatory Bowel Diseases - Data from the Romanian National Registry.
142. Anticoagulation Therapy for Portal Vein Thrombosis in Patients with Cirrhosis in a Tertiary Center Experience.
143. Inflammatory Bowel Disease Management in a Romanian Tertiary Gastroenterology Center: Challenges of the COVID-19 Pandemic.
144. HEPATOCELLULAR CARCINOMA TREATED BY TRANSARTERIAL CHEMOEMBOLIZATION BEFORE LIVER TRANSPLANTATION, A FIVEYEAR SINGLE CENTER EXPERIENCE.
145. Nonalcoholic Fatty Liver Disease: Status Quo.
146. PREDICTIVE FACTORS FOR OPTIMAL WEIGHT LOSS IN PATIENTS WITH MORBID OBESITY AFTER SLEEVE GASTRECTOMY.
147. PRELIMINARY DATA FROM THE VIRAL HEPATITIS MICRO-ELIMINATION PROJECT THROUGH HCV/HBC SCREENING IN PRISONERS IN ROMANIA.
148. PROSPECTIVE EVALUATION OF THE PREVALENCE AND RISK FACTORS OF NONALCOHOLIC FATTY LIVER DISEASE IN ASYMPTOMATIC PATIENTS UNDERGOING SCREENING FOR COLORECTAL CANCER.
149. The role of EUS for accurate preoperative differential diagnosis between GIST and pancreatic rest.
150. Atypical Immunohistochemistry Features in an AFP-producing Colon Cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.